BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serafim TD, Coutinho-Abreu IV, Dey R, Kissinger R, Valenzuela JG, Oliveira F, Kamhawi S. Leishmaniasis: the act of transmission. Trends Parasitol 2021:S1471-4922(21)00168-9. [PMID: 34389215 DOI: 10.1016/j.pt.2021.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Majumder N, Banerjee A, Saha S. A review on new natural and synthetic anti-leishmanial chemotherapeutic agents and current perspective of treatment approaches. Acta Trop 2023;240:106846. [PMID: 36720335 DOI: 10.1016/j.actatropica.2023.106846] [Reference Citation Analysis]
2 Pereira-Filho AA, Queiroz DC, Saab NAA, D'Ávila Pessoa GC, Koerich LB, Pereira MH, Sant'Anna MRV, Araújo RN, Bartholomeu DC, Gontijo NF. Evasion of the complement system by Leishmania through the uptake of C4bBP, a complement regulatory protein, and probably by the action of GP63 on C4b molecules deposited on parasite surface. Acta Trop 2023;:106908. [PMID: 36963597 DOI: 10.1016/j.actatropica.2023.106908] [Reference Citation Analysis]
3 Oguz G, Bilgic HA, Karaaslan C, Mergen H, Kasap OE, Alten B. Differential expression of Phlebotomus tobbi Adler, Theodor & Lourie, 1930 (Diptera: Psychodidae) genes under different environmental conditions. Acta Trop 2023;239:106808. [PMID: 36577475 DOI: 10.1016/j.actatropica.2022.106808] [Reference Citation Analysis]
4 Amini SM, Hadighi R, Najm M, Alipour M, Hasanpour H, Vosoogh M, Vosough A, Hajizadeh M, Badirzadeh A. The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study. Curr Microbiol 2023;80:104. [PMID: 36781499 DOI: 10.1007/s00284-022-03172-1] [Reference Citation Analysis]
5 Amni F, Maleki-Ravasan N, Nateghi-Rostami M, Hadighi R, Karimian F, Meamar AR, Badirzadeh A, Parvizi P. Co-infection of Phlebotomus papatasi (Diptera: Psychodidae) gut bacteria with Leishmania major exacerbates the pathological responses of BALB/c mice. Front Cell Infect Microbiol 2023;13:1115542. [PMID: 36779192 DOI: 10.3389/fcimb.2023.1115542] [Reference Citation Analysis]
6 Rabaan AA, Bakhrebah MA, Mohapatra RK, Farahat RA, Dhawan M, Alwarthan S, Aljeldah M, Al Shammari BR, Al-Najjar AH, Alhusayyen MA, Al-Absi GH, Aldawood Y, Alsaleh AA, Alshamrani SA, Almuthree SA, Alawfi A, Alshengeti A, Alwashmi ASS, Hajissa K, Nassar MS. Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens 2022;12. [PMID: 36678387 DOI: 10.3390/pathogens12010039] [Reference Citation Analysis]
7 Acevedo Ospina H, Guay-Vincent MM, Descoteaux A. Macrophage Mitochondrial Biogenesis and Metabolic Reprogramming Induced by Leishmania donovani Require Lipophosphoglycan and Type I Interferon Signaling. mBio 2022;13:e0257822. [PMID: 36222510 DOI: 10.1128/mbio.02578-22] [Reference Citation Analysis]
8 Guay-Vincent MM, Matte C, Berthiaume AM, Olivier M, Jaramillo M, Descoteaux A. Revisiting Leishmania GP63 host cell targets reveals a limited spectrum of substrates. PLoS Pathog 2022;18:e1010640. [PMID: 36191034 DOI: 10.1371/journal.ppat.1010640] [Reference Citation Analysis]
9 Karimian F, Koosha M, Choubdar N, Oshaghi MA. Comparative analysis of the gut microbiota of sand fly vectors of zoonotic visceral leishmaniasis (ZVL) in Iran; host-environment interplay shapes diversity. PLoS Negl Trop Dis 2022;16:e0010609. [DOI: 10.1371/journal.pntd.0010609] [Reference Citation Analysis]
10 Serafim TD, Iniguez E, Barletta ABF, Doehl JS, Short M, Lack J, Cecilio P, Nair V, Disotuar M, Wilson T, Coutinho-abreu IV, Oliveira F, Meneses C, Barillas-mury C, Andersen J, Ribeiro JM, Beverley SM, Kamhawi S, G.valenzuela J. Genetic exchange in Leishmania is facilitated by IgM natural antibodies.. [DOI: 10.1101/2022.06.09.495557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Guay-vincent M, Matte C, Berthiaume A, Olivier M, Jaramillo M, Descoteaux A. Revisiting Leishmania GP63 host cell targets reveals a limited spectrum of substrates.. [DOI: 10.1101/2022.06.06.494968] [Reference Citation Analysis]
12 Bussotti G, Li B, Pescher P, Vojtkova B, Louradour I, Pruzinova K, Sadlova J, Volf P, Späth GF. Leishmania allelic selection during experimental sand fly infection correlates with mutational signatures of oxidative DNA damage.. [DOI: 10.1101/2022.05.02.490304] [Reference Citation Analysis]
13 Song X, Zhong Z, Gao L, Weiss BL, Wang J. Metabolic interactions between disease-transmitting vectors and their microbiota. Trends in Parasitology 2022. [DOI: 10.1016/j.pt.2022.05.002] [Reference Citation Analysis]
14 Costa-da-silva AC, Nascimento DDO, Ferreira JRM, Guimarães-pinto K, Freire-de-lima L, Morrot A, Decote-ricardo D, Filardy AA, Freire-de-lima CG. Immune Responses in Leishmaniases: An Overview. TropicalMed 2022;7:54. [DOI: 10.3390/tropicalmed7040054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
15 Taslimi Y, Masoudzadeh N, Bahrami F, Rafati S. Cutaneous leishmaniasis: multiomics approaches to unravel the role of immune cells checkpoints. Expert Rev Proteomics 2022;19:213-25. [PMID: 36191333 DOI: 10.1080/14789450.2022.2131545] [Reference Citation Analysis]
16 Maitre A, Wu-Chuang A, Aželytė J, Palinauskas V, Mateos-Hernández L, Obregon D, Hodžić A, Valiente Moro C, Estrada-Peña A, Paoli JC, Falchi A, Cabezas-Cruz A. Vector microbiota manipulation by host antibodies: the forgotten strategy to develop transmission-blocking vaccines. Parasit Vectors 2022;15:4. [PMID: 34983601 DOI: 10.1186/s13071-021-05122-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
17 Lentini G, Dumoulin PC, Carter NS. Intracellular Parasites: Kinetoplastids. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00074-2] [Reference Citation Analysis]
18 Khandibharad S, Nimsarkar P, Singh S. Mechanobiology of immune cells: Messengers, receivers and followers in leishmaniasis aiding synthetic devices. Current Research in Immunology 2022;3:186-198. [DOI: 10.1016/j.crimmu.2022.08.007] [Reference Citation Analysis]
19 Assis LHC, Andrade-Silva D, Shiburah ME, de Oliveira BCD, Paiva SC, Abuchery BE, Ferri YG, Fontes VS, de Oliveira LS, da Silva MS, Cano MIN. Cell Cycle, Telomeres, and Telomerase in Leishmania spp.: What Do We Know So Far? Cells 2021;10:3195. [PMID: 34831418 DOI: 10.3390/cells10113195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Varzandeh M, Mohammadinejad R, Esmaeilzadeh-Salestani K, Dehshahri A, Zarrabi A, Aghaei-Afshar A. Photodynamic therapy for leishmaniasis: Recent advances and future trends. Photodiagnosis Photodyn Ther 2021;36:102609. [PMID: 34728420 DOI: 10.1016/j.pdpdt.2021.102609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]